This study revealed a difference in the expression of G6PDH among subtypes of breast cancer, and analysis of the TCGA data showed relatively increased G6PDH levels in all subtypes of breast tumor compared with normal breast tissue. This evidence concerns the gene H6PD and breast neoplasm.